|
Volumn 102, Issue 18, 2005, Pages 6243-6244
|
Recruiting dendritic cells to improve antibody therapy of cancer
|
Author keywords
[No Author keywords available]
|
Indexed keywords
FC RECEPTOR;
IMMUNOGLOBULIN F(AB) FRAGMENT;
IMMUNOGLOBULIN FC FRAGMENT;
IMMUNOGLOBULIN M ANTIBODY;
INTERLEUKIN 12;
MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;
RITUXIMAB;
TRASTUZUMAB;
ANTIBODY COMBINING SITE;
ANTINEOPLASTIC ACTIVITY;
CANCER;
CELLULAR IMMUNITY;
CYTOTOXICITY;
DENDRITIC CELL;
HUMAN;
IMMUNOTHERAPY;
LYMPHOCYTE FUNCTION;
NATURAL KILLER CELL;
NOTE;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
T LYMPHOCYTE;
TUMOR CELL;
TUMOR IMMUNITY;
ANTIBODIES, MONOCLONAL;
DENDRITIC CELLS;
HUMANS;
IMMUNE TOLERANCE;
IMMUNITY, CELLULAR;
IMMUNIZATION, PASSIVE;
IMMUNOGLOBULIN FAB FRAGMENTS;
IMMUNOGLOBULIN FC FRAGMENTS;
NEOPLASMS;
|
EID: 18144380289
PISSN: 00278424
EISSN: None
Source Type: Journal
DOI: 10.1073/pnas.0502547102 Document Type: Note |
Times cited : (33)
|
References (19)
|